deltatrials
Terminated PHASE4 INTERVENTIONAL NCT00169026

Alcoholism and Schizophrenia: Effects of Clozapine

Sponsor: Commonwealth Research Center, Massachusetts

Conditions Alcohol Abuse Dual Diagnosis Psychotic Disorder Schizoaffective Disorder Schizophrenia Substance Abuse
Interventions Clozapine versus typical (conventional) and atypical antipsychotic medications
Updated 6 times since 2017 Last updated: Mar 12, 2018 Started: May 31, 1999 Completion: Jan 31, 2004
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Commonwealth Research Center, Massachusetts

More terminations from Commonwealth Research Center, Massachusetts

Other Alcohol Abuse trials with similar outcome

Browse all Alcohol Abuse trials

This PHASE4 trial investigates Alcohol Abuse and Dual Diagnosis and is currently terminated or withdrawn. Commonwealth Research Center, Massachusetts leads this study, which shows 6 recorded versions since 1999 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jan 2022 · 12 months · monthly snapshotTerminated~Jan 2022 – ~Jul 2024 · 30 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 24 months · monthly snapshotTerminated

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  3. Jan 2022 — Jul 2024 [monthly]

    Terminated PHASE4

  4. Jan 2021 — Jan 2022 [monthly]

    Terminated PHASE4

  5. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE4

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE4

    First recorded

May 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Commonwealth Research Center, Massachusetts
  • Dartmouth-Hitchcock Medical Center
  • Harvard Medical School (HMS and HSDM)
  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)
  • Novartis
Data source: Dartmouth-Hitchcock Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations